Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

TB Notes Newsletter

(PDF - 1.4M)

No. 1, 2011


Blaya JA, Shin S, Contreras C, Yale G, Suarez C, Asencios L, Kim J, Rodriguez P, Cegielski P, Fraser HSF. Full impact of laboratory information system requires direct use by clinical staff: cluster randomized controlled trial. Journal of the American Medical Informatics Association 2011 Jan; 18(1):11–16.

Brostrom R, Fred D, Heetderks A, Desai M, Song R, Haddad M, Wada R, Bamrah S. Islands of hope: building local capacity to manage an outbreak of multidrug-resistant tuberculosis in the Pacific. American Journal of Public Health 2011 Jan; 101(1):14–18.

Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Metchock B, Starks AM, Hooks DP, Cowan LS, Plikaytis BB, Posey JE. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing in M. tuberculosis. Antimicrob Agents Chemother 2011 Feb 7. [Epub ahead of print].

Castro KG, LoBue P. Bridging implementation, knowledge, and ambition gaps to eliminate tuberculosis in the United States and globally. Emerg Infect Dis 2011 Mar.

Getahun H, Kittikraisak W, Heilig CM, Corbett E, Ayles H, Cain KP, Grant AD, Churchyard G, Kimerling M, Shah S, Lawn SD, Wood R, Maartens G, Granich R, Date A, Varma JK. Development of a standardized screening rule for tuberculosis in people living with HIV in resource constrained settings: individual participant data meta-analysis of observational studies. PLoS Medicine 2011;8:e1000391.

Goodchild M, Sahu S, Wares F, Dewan P, Shukla RS, Chauhan LS, Floyd K. A cost-benefit analysis of scaling up tuberculosis control in India. Int J Tuberc Lung Dis 2011 Mar; 15(3): 358-62.

Hiraishi Y, Nandakumar S, Choi S.-O, Lee JW, Kim Y-C, Posey JE, Sable SB, Prausnitz MR. Bacillus Calmette-Guerin vaccination using a microneedle patch. Vaccine 2011 Mar 21; 29 (14): 2626–2636.

Kvasnovsky CL, Cegielski JP, Erasmus R, Siwisa NO, Thomas K, Van Der Walt ML. Extensively drug-resistant TB in Eastern Cape, South Africa: high mortality in HIV negative and HIV positive patients. JAIDS 2011 Feb 4. [Epub ahead of print.]

Manangan LP, Salibay CJ, Wallace RW, Kammerer S, Pratt R, McAllister L, Robison V. Tuberculosis among persons born in the Philippines and living in the United States, 2000–2007. American Journal of Public Health 2011 January; 101(1): 101–111.

Marks SM, Magee E, Robison V. Patients diagnosed with tuberculosis at death or who died during therapy: association with the human immunodeficiency virus. Int J Tuberc Lung Dis 2011 Apr; 15(4): 465–70.

Mitruka K, Oeltmann JE, Ijaz K, Haddad MB. Tuberculosis outbreak investigations in the United States, 2002–2008. Emerg Infect Dis [serial on the Internet]. 2011 Mar.

Moonan PK, Quitugua TN, Pogoda JM, Woo G, Drewyer GB, Sahbazian B, Dunbar D, Jost KC Jr, Wallace C, Weis SE. Does directly observed therapy (DOT) reduce drug- resistant tuberculosis?  BMC Public Health 2011; 11(1):19.External Web Site Icon

Perri BR, Proops D, Moonan PK, Munsiff SS, Kreiswirth BN, Goranson C, Ahuja SD. Mycobacterium tuberculosis cluster with developing drug resistance, New York, New York, USA, 2003-2009. Emerg Infect Dis 2011 Mar; 17(3): 372–8.

Podewils L J, Holtz T, Riekstina V, Skripconoka V, Zarovska E, Kirvelaite G, Kreigere E, Leimane V.  Impact of malnutrition on clinical presentation, clinical course, and mortality in MDR-TB patients. Epidemiology & Infection 2011 January; 139(1): 113–120.

Velasquez GE, Yagui M, Cegielski JP, Asencios L, Bayona J, Bonilla C, Jave HO, Yale G, Susrez C, Atwood S, Contreras CC, Shin SS. Targeted drug-resistance testing strategy for multidrug-resistant tuberculosis detection, Lima, Peru, 2005–2008. Emerg Infect Dis 2011 Mar; 17(3): 432–440.

Vinnard C, Winston CA, Wileyto EP, MacGregor RR, Bisson GP. Isoniazid-resistant tuberculous meningitis, United States, 1993–2005. Emerg Infect Dis 2011 Mar.


Contact Us:
  • Centers for Disease Control and Prevention
    Division of Tuberculosis Elimination (DTBE)
    1600 Clifton Rd., NE
    MS E10
    Atlanta, GA 30333
  • 800-CDC-INFO
    TTY: (888) 232-6348
  • Contact CDC–INFO The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #